TOI
The Oncology Institute Inc.
$3.40
-$0.08(-2.30%)
58
Overall
--
Value
66
Tech
50
Quality
Market Cap
$326.33M
Volume
1.57M
52W Range
$0.13 - $4.50
Target Price
$7.00
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $187.5M | $203.0M | $252.5M | $324.2M | $393.4M | ||
| Total Revenue | $187.5M | $203.0M | $252.5M | $324.2M | $393.4M | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $150.6M | $162.2M | $200.4M | -- | -- | ||
| GROSS PROFIT | |||||||
| Gross Profit | $36.9M | $40.8M | $52.1M | $324.2M | $393.4M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $195.7M | $248.9M | $124.1M | $401.3M | $453.5M | ||
| Selling, General & Administrative | $41.9M | $83.4M | $119.7M | $113.9M | $107.8M | ||
| Selling & Marketing Expenses | $175.0K | -- | -- | -- | -- | ||
| General & Administrative Expenses | $41.9M | $83.4M | $119.7M | $113.9M | $107.8M | ||
| Salaries & Wages | $-199.7K | -- | -- | -- | -- | ||
| Depreciation & Amortization | $3.2M | $3.3M | $4.4M | $5.9M | $6.3M | ||
| Depreciation & Amortization | $3.2M | $3.3M | $4.4M | $5.9M | $6.3M | ||
| Amortization | $19.6M | $26.7M | $23.9M | $24.1M | $21.1M | ||
| OPERATING INCOME | |||||||
| Operating income | $-8.2M | $-45.9M | $-82.0M | $-77.0M | $-60.1M | ||
| EBITDA | $-11.3M | $-7.9M | $8.4M | $-71.0M | $-52.1M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $347.0K | $320.0K | $4.1M | $11.0K | $8.0K | ||
| Intinc | $254.1K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-347.0K | $-320.0K | $-4.1M | $-11.0K | $-8.0K | ||
| Gain on Sale of Securities | -- | $24.9M | $24.2M | $878.0K | $2.7M | ||
| Other Income/Expense | $6.3M | $-34.6M | $76.0M | $-691.0K | $-3.0M | ||
| Other Special Charges | $-6.3M | $9.7M | $2.5M | $-990.0K | $254.0K | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | $12.2M | $6.0M | $-38.0K | $83.2M | -- | ||
| Special Income Charges | $-12.2M | $-6.0M | $-9.9M | $-16.9M | -- | ||
| Impairment of Capital Assets | -- | -- | $9.9M | $16.9M | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-14.5M | $-11.3M | $4.0M | $-83.1M | $-64.7M | ||
| Pre-Tax Income | $-14.8M | $-11.6M | $-91.0K | $-83.1M | $-64.7M | ||
| INCOME TAX | |||||||
| Tax Provision | $-493.0K | $-671.0K | $-243.0K | $-36.0K | -- | ||
| NET INCOME | |||||||
| Net Income | $-14.3M | $-10.9M | $152.0K | $-83.1M | $-64.7M | ||
| Net Income (Continuing Operations) | $-14.3M | $-10.9M | $152.0K | $-83.1M | $-64.7M | ||
| Net Income (Discontinued Operations) | $-14.3M | $-10.9M | $152.0K | $-83.1M | $-64.7M | ||
| Net Income (Common Stockholders) | $-14.3M | $-10.6M | $68.0K | $-67.9M | $-53.0M | ||
| Normalized Income | -- | $-30.6M | -- | -- | $-64.0M | ||
| TOTALS | |||||||
| Total Expenses | $346.3M | $411.0M | $324.5M | $401.3M | $453.5M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $28.6M | $66.2M | $72.8M | $73.7M | $75.0M | ||
| Average Shares Outstanding (Diluted) | -- | $66.2M | $80.6M | $73.7M | $75.0M | ||
| Shares Outstanding | $28.8M | $93.5M | $74.6M | $74.3M | $75.8M | ||
| Basic EPS | $-0.08 | $-0.16 | -- | $-0.92 | $-0.71 | ||
| Basic EPS (Continuing Operations) | $-0.08 | $-0.16 | -- | $-0.92 | $-0.71 | ||
| Diluted EPS | $-0.08 | $-0.16 | $-0.21 | $-0.92 | $-0.71 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.16 | $-0.21 | $-0.92 | $-0.71 | ||
| OTHER METRICS | |||||||
| Accrued Preferred Stock Dividends | -- | $10.6M | $17.0M | $67.9M | $53.0M | ||
| Acquisition Expense | -- | $476.0K | $790.0K | $114.0K | -- | ||
| Other Gand A | $41.9M | $83.4M | $119.7M | $113.9M | $107.8M | ||
| Other Write Off | -- | $48.0K | $307.0K | $2.0M | -- | ||
| Otherunder Preferred Stock Dividend | -- | $10.6M | $17.0M | $67.9M | $53.0M | ||
| Preferred Stock Dividends | -- | $10.6M | $17.0M | $67.9M | $53.0M | ||
| Restruct | $12.2M | $6.0M | $-38.0K | $83.2M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TOI | $3.40 | -2.3% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get The Oncology Institute Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW